XML 59 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Contractual Revenue (Details) - Roche Agreement [Member] - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2013
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Dec. 31, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                
Non-refundable upfront payment   $ 35,000,000                            
Amortization       $ 3,600,000 $ 3,600,000 $ 3,600,000 $ 3,600,000 $ 3,600,000 $ 3,600,000 $ 3,600,000 $ 1,700,000 $ 1,700,000 $ 1,700,000 $ 1,700,000 $ 1,700,000  
Deferred revenue       $ 1,300,000                        
Collaborative arrangement expiration Feb. 10, 2017                              
Period until expiration upon notice given 60 days                              
Deferred revenue, revenue recognized     $ 1,300,000       20,000,000   10,000,000              
Maximum potential for additional payments to be recognized upon the achievement of certain development milestones   $ 40,000,000                            
Remaining potential for additional payments to be recognized upon the achievement of certain development milestones $ 0   $ 0                          
First Milestone [Member]                                
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                
Deferred revenue, revenue recognized                               $ 10,000,000
Second Milestone [Member]                                
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                
Deferred revenue, revenue recognized                 $ 10,000,000              
Third (Final) Milestone [Member]                                
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                
Deferred revenue, revenue recognized             $ 20,000,000